Literature DB >> 21132227

[Impact of respiratory distress syndrome in very low birth weight infants: a multicenter South-American study].

Elisa Fehlmann1, José L Tapia, Rocío Fernández, Aldo Bancalari, Jorge Fabres, Ivonne D'Apremont, María J García-Zattera, Carlos Grandi, José M Ceriani Cernadas.   

Abstract

OBJECTIVE: To analyze the incidence, risk factors, major morbidity, mortality and resource employment in very low birth weight infants (< 1500 g) with respiratory distress syndrome (RDS).
METHODS: Descriptive study using prospectively obtained on-line information from a data base of 20 units belonging to the South American Neocosur Network. A total of 5991 VLBW infants were registered during years 2002-2007.
RESULTS: The mean gestacional age was 29.1 weeks (95% CI 29.06-29.21) and the mean of birth weight was 1100.5 g (95% CI 1093.79-1107.37). The global incidence of RDS was 74% (95% CI 73-75). Antenatal steroids were administered to 73% of this population. The main risk factor was lower gestational age (p< 0.001); where as prenatal steroids (OR: 0.59; 95% CI 0.49-0.72), female gender (OR: 0.77; 95% CI 0.67-0.89) and premature rupture of membranes (OR: 0.81; 95% CI 0.68-0.96) were protective factors. Antenatal steroids was also associated with a decrease in mortality in those infants that presented with RDS (OR: 0.40; 95% CI 0.34-0.47). Use of resources was higher in the group with RDS, with a greater use of surfactant (74.3% vs. 7.3%, p< 0.001), mechanical ventilation (82.1% vs. 23.8%, p< 0.001), and more days of oxygen (median of 8 vs. 1 day, p< 0.001) and hospitalization (median of 61 vs. 45 days, p< 0.001). RDS was associated to an increase risk in the incidence of ROP, PDA, late onset sepsis, severe IVH and oxygen requirement at 36 weeks of corrected gestational age.
CONCLUSIONS: RDS had a high incidence in very low birth weight infants, despite the frequent use of antenatal steroids. VLBW Infants with RDS had a higher mortality and an increase risk of relevant morbidity. RDS also increased use of resources.

Entities:  

Mesh:

Year:  2010        PMID: 21132227     DOI: 10.1590/S0325-00752010000500004

Source DB:  PubMed          Journal:  Arch Argent Pediatr        ISSN: 0325-0075            Impact factor:   0.635


  5 in total

1.  Management of Neonatal Respiratory Distress Syndrome Employing ACoRN Respiratory Sequence Protocol versus Early Nasal Continuous Positive Airway Pressure Protocol.

Authors:  Pedram Niknafs; Asadallah Faghani; Seyed-Abolfazl Afjeh; Mehdi Moradinazer; Bahareh Bahman-Bijari
Journal:  Iran J Pediatr       Date:  2014-01-24       Impact factor: 0.364

Review 2.  Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.

Authors:  M J Sankar; N Gupta; K Jain; R Agarwal; V K Paul
Journal:  J Perinatol       Date:  2016-05       Impact factor: 2.521

3.  Genetic Polymorphisms of SP-A, SP-B, and SP-D and Risk of Respiratory Distress Syndrome in Preterm Neonates.

Authors:  Hong-Yu Chang; Fang Li; Feng-Sheng Li; Cheng-Zhong Zheng; Yan-Zhe Lei; Jing Wang
Journal:  Med Sci Monit       Date:  2016-12-24

4.  National scale of neonatal CPAP to district hospitals in Malawi improves survival for neonates weighing between 1.0 and 1.3 kg.

Authors:  Jennifer Carns; Sara Liaghati-Mobarhan; Aba Asibon; Alfred Chalira; Norman Lufesi; Elizabeth Molyneux; Maria Z Oden; Rebecca Richards-Kortum; Kondwani Kawaza
Journal:  Arch Dis Child       Date:  2021-11-01       Impact factor: 4.920

5.  RETREATMENT WITH SURFACTANT IN VERY LOW BIRTH WEIGHT PRETERM INFANTS: RISK PREDICTORS AND THEIR INFLUENCE ON NEONATAL OUTCOMES.

Authors:  Walusa Assad Gonçalves Ferri; Adriana Carnevale da Silva; Eliana Motta Fernandes Sacramento; Cristina Calixto; Davi Casale Aragon; Jamil Pedro de Siqueira Caldas
Journal:  Rev Paul Pediatr       Date:  2020-11-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.